While m6A deposition in mRNAs occurs in the nucleus and elevated METTL3 levels are associated with survival of acute myeloid leukemia24,30, non-catalytic functions of METTL3 outside the nucleus benefit lung cancer cells23,25. The gene discussed is METTL3; the disease is lung carcinoma.